Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Mar. 01, 2014	Mar. 02, 2013
Operating activities:
Net income	$ 20,739	$ 13,676
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	1,966	2,178
LIFO expense	608	551
Stock-based compensation	1,388	996
Deferred income taxes including valuation allowance	(152)	(1,550)
Postretirement benefit income and deferred compensation expense	(405)	284
(Benefit) provision for doubtful accounts	(1)	6
Gain on disposal of property	(702)	(26)
Gain on life insurance	0	(509)
Increase in cash surrender value of life insurance policies	(440)	(547)
Change in assets and liabilities:
Inventories	(12,356)	(37,401)
Receivables, prepaid and other assets	(40,056)	(6,334)
Income taxes and unrecognized tax benefits	1,269	1,618
Accounts payable and accrued expenses	536	3,052
Postretirement and deferred compensation benefits	(1,924)	(2,136)
Net cash used in operating activities	(29,530)	(26,142)
Investing activities:
Proceeds from the sale of investments, at par	2,350	250
Proceeds from life insurance	0	974
Purchases of property and equipment	(3,772)	(2,443)
Proceeds from the sale of property	2,392	614
Repayments of COLI borrowings	0	(1,371)
Other	(105)	151
Net cash provided by (used in) investing activities	865	(1,825)
Financing activities:
Payments for purchases of common stock	(21,484)	(8,367)
Proceeds from exercise of stock options	2,080	0
Other	50	(114)
Net cash used in financing activities	(19,354)	(8,481)
Net decrease in cash and cash equivalents	(48,019)	(36,448)
Cash and cash equivalents at beginning of period	64,277	62,683
Cash and cash equivalents at end of period	16,258	26,235
Supplemental cash flow disclosure:
Income taxes paid, net of refunds	$ 8,200	$ 5,670